To further investigate whether FGL1 could promote EMT in ccRCC, we used IHC to analyze the correlation between FGL1 and EMT markers including E-cadherin, N-cadherin, and Vimentin in ccRCC tissues and paired normal tissues. This evidence concerns the gene CDH2 and nonpapillary renal cell carcinoma.